News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
Lizzo had earlier revealed she had lowered her body mass index (BMI) by 10.5 and lost 16% of her body fat since January 2023.
Kate Beckinsale has addressed concerns from fans about her sudden weight loss in a fiery response on Instagram. Kate ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...
Kate Beckinsale addressed her dramatic weight loss after a fan weighed in on her appearance via social media. On Tuesday, the ...
Jason Kelce and Travis Kelce are laughing off a surprising consequence of Jason’s recent weight loss.
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
Lizzo, who is on the cover of 'Women's Health' 's latest issue, discussed the three meals that helped her lose weight in the ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results